. Like IL-4, IL-10 is secreted by Th2 lymphocytes and is inhibitory to several macrophage functions. In the present study, IL-10 was tested and compared to IL-2, IL-4, IL-6, and IFNy for its capacity to modulate synthesis of 92-kD gelatinase, interstitial collagenase and TIMP in human macrophages and monocytes. We found that IL-10, just like IL-4, inhibited the production of 92-kD gelatinase and blocked LPS-, as well as killed Staphylococcus aureus-induced, interstitial collagenase production. The principal finding of this study, however, was that IL-10, in distinction to IL-4, produced a dose-dependent stimulation in the biosynthesis of TIMP-1. TIMP-2 production was not affected. IL-10 regulated the expression of 92-kD gelatinase and TIMP-1 at the pretranslational level. Furthermore, IL-10 regulation was cell typespecific, as it had no effect on the production of metalloproteinases or TIMP by human fibroblasts. In summary, IL-10 has a potent and unique effect upon tissue macrophages and blood monocytes by enhancing TIMP-1 production while decreasing metalloproteinase biosynthesis. (J. Clin. Invest. 1995. 96:2304-2310
Introduction
Macrophages play an important role in the immune response, in acute and chronic inflammation, and they participate in degra-dation and remodelling of extracellular matrix (ECM) .' These cells are able to modulate matrix turnover by synthesizing and secreting several metalloproteinases and their specific inhibitors, tissue inhibitors of metalloproteinases (TIMPs) (1, 2) . Such enzymes include interstitial collagenase, stromelysin, gelatinases of 92 and 72 kD (2, 3) of which the former is predominant (4), and a newly described metalloelastase (5) . Macrophages also produce the counter-regulatory inhibitors TIMP-1 and TIMP-2 (6, 7). TIMP-1 interacts with the active forms of interstitial collagenase and stromelysin as well as with the active and latent form of 92-kD gelatinase. TIMP-2 specifically binds the proenzyme and active species of 72-kD gelatinase. Both TIMPs inhibit the activity of the fully competent metalloproteinases and also diminish metalloproteinase precursor activation (8) .
The prominence of mononuclear phagocytes in inflammatory sites is the result of their attraction by mediators such as leukotrienes, chemokines and complement split products. These cells, in addition to fibroblast-like cells, may contribute significantly to the degradation and pathological remodelling of ECM. Support for this concept is found by in situ hybridization studies demonstrating high levels of interstitial collagenase and stromelysin mRNA in macrophage-like cells of the rheumatoid synovial pannus (9) and also in lipid-laden macrophages of atherosclerotic plaques (10) . In addition, during inflammatory processes, other migratory cells are often present, including B-and T lymphocytes. T lymphocytes can interact with mononuclear cells through released peptides, such as lymphokines (11) or by direct cell-cell contact (12) . The lymphokine profiles of Th, and Th2 T helper cells are distinct and may be able to modify specific macrophage functions, in particular their ability to degrade ECM (13) .
IL-10 is primarily a product of activated Th2 cells (14) and of LPS-stimulated monocytes (15) , but it is also synthesized by B cells (16) and keratinocytes (17) . Among the different cell types affected by IL-10, monocyte-macrophages appear to be particularly modified in regard to their function, morphology, and phenotype. For instance, IL-1O strongly diminishes the production of IL-la, IL-1,3, IL-6, IL-8, TNFa, GM-CSF, and G-CSF by LPS-activated human monocytes (15) . It also inhibits the antigen-specific proliferative T cell response by reducing the antigen-presenting capacity of monocytes via downregulation of class II MHC molecules (18) . Thus, IL-10 appears to be a potent suppressor of the immune response.
To determine the effect of IL-1O upon the capacity of macrophages to modulate ECM degradation, we compared the ability of this cytokine to regulate the production of matrix metalloproteinases and TIMPs to that of IL-4, another product of activated Th2 T helper cells which has been previously shown to inhibit the expression of interstitial collagenase and 92-kD gelatinase by mononuclear phagocytes without affecting the synthesis of TIMP-1 (19, 20 Cell culture. Human alveolar macrophages were harvested from the uninvolved lung tissue of individuals undergoing surgical resection for pulmonary carcinoma (21). Segments or lobes were lavaged and processed as described previously (20) . The adherent macrophages were cultured at a concentration of 1 x 106 cells/ml in the presence of RPMI-1640 medium, containing 5% FCS, penicillin ( 100 U/ml), streptomycin (100 ng/ml) and 2 mM L-glutamine in 24-well cluster plates (Costar Corp., Cambridge, MA). The cells were maintained in humidified 95% air/ 5% CO2. Cultures were treated with medium alone, killed Staph, LPS and/or various concentrations of the different cytokines for 48 h. The conditioned media were then collected and stored at -20°C until further analysis.
Peripheral blood monocytes were obtained by phlebotomy of normal adult volunteers. The mononuclear fraction was purified by Ficoll-Hypaque gradient centrifugation (Pharmacia Fine Chemicals, Piscataway, NJ). Monocytes were plated at a concentration of 1 X 106 cells/ml and isolated by adherence to plastic at 37°C for 1 h. Nonadherent cells were washed away three times with PBS and the resulting adherent cells were cultured in the presence of RPMI-1640 medium, containing 5% FCS, penicillin (100 U/ml), streptomycin (100 ng/ml) and 2 mM L-glutamine in 24-well cluster plates. The cells were maintained in humidified 95% air / 5% C02 for 48 h. Cells were then treated with culture medium alone or various concentrations of IL-4, IL-10, and/or aIL-O0. After 48 h of incubation at 37°C, the conditioned media were collected and stored at -20°C until further analysis.
Dermal fibroblasts were obtained by proteolytic dispersion of human skin, and lung fibroblasts were obtained by proteolytic dispersion of the uninvolved lung tissue of individuals undergoing surgical resection (22) . Fibroblasts were plated in 96-well cluster plates (Costar Corp.) at 2 x 104 cells per 200 ml MEM containing 5% heat-inactivated FCS. After 36 h of culture, the fibroblast monolayers were fed with new fresh MEM, and various cytokines were added for 72 h. Conditioned media were then collected and the content of interstitial collagenase and TIMP-1 was determined by ELISA.
Enzyme determinations. Samples of conditioned media were subjected to enzyme-linked immunosorbent assays (ELISA). The assays for interstitial collagenase, 92-kD gelatinase and TIMP-1 have been previously described (23) (24) (25) . The sensitivity for all protein assays is 10 ng/ml.
Metabolic labeling and immunoprecipitation studies. All samples subjected to immunoprecipitation were conditioned in the presence of [35S] methionine for 24 h. To determine the effects of IL-10 on the production of metalloproteinases by macrophages, cells were exposed to this cytokine for a period of 24 h in RPMI-1640 culture medium containing 5% FCS and then washed three times in PBS. For the labeling period of 24 h, RPMI-1640 culture medium was replaced with otherwise identical methionine-free RPMI-1640 medium (GIBCO) containing 50 MCi/ml of [35S]methionine (Amersham Corp., Zurich, Switzerland) and dialyzed 5% FCS. After 24 h of incubation, the samples containing the labeled proteins were collected and stored at -70'C until further analysis. For immunoprecipitation, polyclonal antisera to human interstitial collagenase, TIMP-1 and TIMP-2 were used as reported previously (3, 8, 26) . Processed samples were applied to 12% polyacrylamide slab gels and electrophoresis was performed as described (27) . The gels were exposed to HyperfilmT film (Amersham, CEA AB, Solna, Sweden) for 24-48 h at -700C.
RNA preparation and Northern hybridization. Total cellular RNA from 1 x 107 alveolar macrophages, untreated or exposed to IL-6 or various concentrations of IL-10, was extracted by the guanidine isothiocyanate method and purified by cesium chloride density gradient centrifugation (28) . Total RNA (10 Ag) was processed for Northern analysis as described previously (23) . Membranes were sequentially hybridized at 58°C overnight with 32P-labeled cDNA probes for 92-kD gelatinase (4) and TIMP-I (kindly provided by David Carmichael, Synergen, Boulder, CO). The 92-kD cDNA plasmid was digested with BamHI and XbaI in order to obtain a probe of 0.56 Kb as described previously (29) . 18 S and 28 S rRNA bands stained with ethidium bromide were used as a control. Filters were then exposed to Hyperfilm2 film (Amersham, CEA AB, Solna, Sweden) for 24-48 h at -70°C.
Results
IL-JO suppresses MMP and stimulates TIMP-J production by human mononuclear phagocytes. To determine whether IL-10 regulates the production of 92-kD gelatinase and TIMP by human alveolar macrophages, the cells were exposed to increasing concentrations of this cytokine. For comparison, IL-4 was also tested. As shown in Fig. 1 , macrophages under basal conditions released both 92-kD gelatinase and TIMP-1 in culture. The addition of either IL-10 or 11L-4 resulted in a dose-dependent decrease of 92-kD enzyme production. 1L-4 at 10 ng/ml inhibited gelatinase production by 55% whereas an identical concentration of IL-10 caused a 37% decrease. Interestingly, IL-10 strongly stimulated the production of TIMP-1 in a dose-dependent manner, whereas IL-4, at various concentrations, failed to affect TIMP-1 synthesis. The time course of IL-10 regulation of 92-kD gelatinase and TIMP-1 production was next examined. As shown in Fig. 2 , 1L-10 inhibited the production of 92-kD gelatinase, but only 12-24 h after the addition of the cytokine, whereas stimulation of TIMP-1 synthesis occurred earlier, between 4-12 h of exposure.
To determine whether the activities of these cytokines extended to less differentiated forms of mononuclear phagocytes, we studied human peripheral blood monocytes exposed to 1L-10 and IL-4. Both cytokines suppressed the production of 92-U) gelatinase in monocytes in a dose-dependent manner ( 3 A). However, only IL-10 significantly increased TIMP-1 production; IL-4 did not alter the release of metalloproteinase inhibitor (Fig. 3 B) .
To verify the specificity of IL-10 effects, antiserum to this cytokine was used. As shown in Table I , IL-10 decreased the basal release of 92-kD gelatinase in both alveolar macrophages and blood monocytes, an effect which was reversed by the simultaneous presence of cytokine antibody. Furthermore, IL-10 markedly stimulated TIMP-I production by both tissue macrophages and blood monocytes; this effect was also blocked by IL-1O antibody. In contrast a nonspecific antibody (mIgG) was totally unable to block the effects of IL-1O on both enzyme and inhibitor.
Effect of IL-1O on activated alveolar macrophages. To determine whether IL-10 would also modify the biological function of activated alveolar macrophages, cells were treated with either killed Staph. or LPS and were simultaneously exposed to the cytokine. As shown in Table II , the addition of killed Staph. markedly induced the expression of interstitial collagenase and 92-kD gelatinase. IL-10 added simultaneously abrogated this response, reducing metalloproteinase production to baseline levels. Killed Staph. also induced the production of TIMP-1; this effect was enhanced nearly fourfold by IL-10. Thus, IL-10 exhibited identical activities upon both basal macrophages and cells stimulated by killed Staph.
Macrophage activation was also studied in response to LPS. Cells were cultured for 48 h in the presence or absence of LPS, proteins were immunoprecipitated with antisera specific for interstitial collagenase, TIMP-1 and TIMP-2. Fig. 4 demonstrates that basal macrophages failed to synthesize collagenase, whose expression was massively induced by LPS. In the presence of IL-10, LPS-stimulated biosynthesis of interstitial collagenase was substantially reduced. Both basal and LPS-stimulated levels of TIMP-l were markedly increased by exposure of the cells to IL-1O. Labeled cellular proteins from the same experiment were also immunoprecipitated with antiserum specific for TIMP-2. As shown in Fig. 4 Relative effectiveness of various cytokines in modifying the production of92-kD gelatinase and TIMP-J by alveolar macrophages. We next compared the relative efficacy of different soluble mediators released by activated T-lymphocytes, including IL-2, IL-4, LL-6, IL-10, and IFNy, to regulate the expression of 92-kD gelatinase and TLMP-1 by macrophages. Interstitial collagenase was not measured because it is not secreted basally nor can it be induced by any of these cytokines. As shown in Fig. 6 , 92-kD gelatinase and TIMP-1 were produced by macrophages under basal conditions in culture. The addition of 1L-4 (10 ng/ml), IL-10 ( 10 ng/ml), and IFNy (500 U/ml) decreased 92-kD enzyme production by 60, 30 , and 76%, respectively (Fig. 6 A) . Although synthesis of 92-kD gelatinase was reduced on average by 35% with 10 ng/ml of IL-10, both higher and lower degrees of inhibition were observed among the different individuals' alveolar macrophages (Figs. 1 and 4 , Tables I and  II) . Furthermore, cell supernatants subjected to gelatin zymography and subsequently scanned densitometrically showed a decrease of at least 30% in 92-kD gelatinolytic activity (data not shown). 11L-6 and IL-2 failed to affect production of 92-kD gelatinase by macrophages.
Of the cytokines tested, only IL-10 (10 ng/ml) and 11L-6 (10 ng/ml) stimulated the production of TIMP-1 by alveolar macrophages (Fig. 6 ). Both cytokines increased TIMP-1 expression by nearly 5-fold above baseline levels. Thus, IL-10 was the only cytokine to simultaneously reduce MMP and enhance TIMP-1 production.
Capacity of IL-JO to influence the production of interstitial collagenase and TIMP-I by human dermal and lungfibroblasts. To assess the cell type-specificity of the effect of IL-10, we studied human dermal and lung fibroblasts treated with the cytokine. Cells were cultured under control conditions and also in the presence of added IL-10 and/or IL-1/3. In the case of skin fibroblasts, IL-10 failed to inhibit the basal production of interstitial collagenase and reduced IL-1-stimulated enzyme Table II. production only marginally (by < 20%) (Table III) . Furthermore, the production of TIMP-1 was unaffected by IL-10. In contrast, IL-lp strongly increased interstitial collagenase production and slightly upregulated the production of TIMP-1. For the lung fibroblasts, IL-10 also failed to modify the expression of either interstitial collagenase or TIMP-1.
Discussion
T lymphocytes and macrophages, attracted to damaged sites by various chemotactic factors are often in close spatial proximity (15) ; it also inhibits the antigen-specific proliferative T cell response by reducing the antigen presenting capacity of monocytes via down-regulation of class II MHC antigen (18) . Furthermore, IL-10 decreases the production of reactive oxygen intermediates (H202) and reactive nitrogen intermediates (NO) by macrophages (33) . In our study, we have analyzed the effects of IL-10 upon the monocyte-macrophage's capacity to modulate extracellular matrix turnover. We have shown IL-10 to be unique among lymphokines in that it simultaneously decreases the production of interstitial collagenase and 92-kD gelatinase while enhancing TIMP-1 expression. All these combined activities on mononuclear cells would be expected to lead to powerful antiinflammatory effects. The intracellular second messenger molecules induced by IL-1O in mononuclear phagocytes have not been studied yet.
TIMP-1 is responsible for controlling the enzymatic activity of interstitial collagenase, stromelysin and 92-kD gelatinase. Its expression in fibroblasts is stimulated by a variety of agents such as IL-1,f (34) , TGF,/ (35) , phorbol esters (34) , and retinoids (36) . IL-6 has recently been shown to specifically stimulate TIMP-1 production in fibroblasts (37) and alveolar macrophages (20) , with inconsistent effect upon metalloproteinase release. We have found IL-10 to be as effective as IL- TIMP-1 (ngtm 6 in inducing TIMP-production by alveolar macrophages, both basal levels and in cells activated with LPS or killed Staph. TIMP-2 is primarily responsible for controlling the activity of 72-kD gelatinase (38) . This inhibitor is produced constitutively at high levels by human fibroblasts (8) and alveolar macrophages (7). In macrophages, basal secretion of TIMP-2 is markedly reduced by LPS, denatured type I collagen and zymosan, factors which stimulate TIMP-1 production by the same cells (7) . In contrast to its effects upon the production of TIMP- to stimulate the mRNA expression of both interstitial collagenase and stromelysin (39) . Examples of such cell type-specific control are becoming more commonplace in metalloproteinase biology. For example, TGFI3 has been shown to inhibit the production of metalloproteinases and augment the biosynthesis of TIMP-1 in fibroblasts (35) . Yet, this cytokine stimulates 92-kD gelatinase production in both keratinocytes (40) and monocytes (41) . We have recently found that activated T cells can stimulate the metalloproteinase production of human mononuclear phagocytes by a mechanism which involves the expression of one or more cell surface glycoproteins induced via direct cell-cell contact (42) . It is thus tempting to speculate that such activated T lymphocytes may utilize the secretion of cytokines versus cell-cell contact as strategies to respectively downregulate and upregulate the capacity of nearby mononuclear phagocytes to 
